Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland)
- PMID: 12948282
- DOI: 10.1023/a:1024840823328
Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland)
Abstract
Objective: Manganese superoxide dismutase (MnSOD) is a mitochondrial enzyme that plays a key role in protecting the cell from oxidative damage. A polymorphism in the mitochondrial targeting sequence (a valine to alanine substitution), thought to alter transport of the enzyme into mitochondria, has been associated with increased risk for breast cancer with a more pronounced association among women with low intake of dietary antioxidants. We examined the role of MnSOD in the development of prostate cancer in a large, randomized cancer prevention trial of male smokers, the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. We hypothesized that MnSOD may be associated with prostate cancer and that long-term antioxidant supplementation (alpha-tocopherol 50 mg/day for five to eight years) could modify the effect on risk.
Methods: Logistic regression was used to estimate these associations among 197 cases and 190 controls genotyped and matched for age, intervention group, and clinic.
Results: Men homozygous for the MnSOD ala allele had a 70% increase in risk over men homozygous for the val allele (odds ratio, OR = 1.72, 95% confidence interval, CI = 0.96-3.08, p = 0.07). Supplementation with alpha-tocopherol had no impact on the MnSOD-prostate cancer association. Although there was no difference in the association with disease stage, men homozygous for MnSOD ala (compared to MnSOD val/val or val/ala) showed a three-fold risk increase for high-grade tumors (OR = 2.72, 95% CI: 1.15-6.40, p = 0.02).
Conclusion: These data suggest an effect of the MnSOD ala/ala genotype on the development of prostate cancer. Our observation of a stronger association with high-grade tumors may have prognostic implications that should also be pursued.
Similar articles
-
Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.Eur J Cancer. 2009 Nov;45(16):2874-81. doi: 10.1016/j.ejca.2009.04.024. Epub 2009 May 19. Eur J Cancer. 2009. PMID: 19467856 Review.
-
Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review.Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3298-305. doi: 10.1158/1055-9965.EPI-08-0235. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 19064542 Review.
-
Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.Cell Biochem Funct. 2008 Oct;26(7):771-7. doi: 10.1002/cbf.1504. Cell Biochem Funct. 2008. PMID: 18646267
-
Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.Cancer Res. 2005 Mar 15;65(6):2498-504. doi: 10.1158/0008-5472.CAN-04-3535. Cancer Res. 2005. PMID: 15781667
-
Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer.Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):989-96. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15184255
Cited by
-
The Association of Polymorphisms in Genes Encoding Antioxidant Enzymes GPX1 (rs1050450), SOD2 (rs4880) and Transcriptional Factor Nrf2 (rs6721961) with the Risk and Development of Prostate Cancer.Medicina (Kaunas). 2022 Oct 9;58(10):1414. doi: 10.3390/medicina58101414. Medicina (Kaunas). 2022. PMID: 36295574 Free PMC article.
-
Val16A SOD2 Polymorphism Promotes Epithelial-Mesenchymal Transition Antagonized by Muscadine Grape Skin Extract in Prostate Cancer Cells.Antioxidants (Basel). 2021 Feb 1;10(2):213. doi: 10.3390/antiox10020213. Antioxidants (Basel). 2021. PMID: 33535682 Free PMC article.
-
Association between SOD2 V16A variant and urological cancer risk.Aging (Albany NY). 2020 Jan 12;12(1):825-843. doi: 10.18632/aging.102658. Epub 2020 Jan 12. Aging (Albany NY). 2020. PMID: 31929112 Free PMC article.
-
Role of SOD2 Ala16Val polymorphism in primary brain tumors.Biomed Rep. 2019 Mar;10(3):189-194. doi: 10.3892/br.2019.1192. Epub 2019 Feb 7. Biomed Rep. 2019. PMID: 30906548 Free PMC article.
-
Association between MnSOD Val16Ala Polymorphism and Cancer Risk: Evidence from 33,098 Cases and 37,831 Controls.Dis Markers. 2018 Sep 2;2018:3061974. doi: 10.1155/2018/3061974. eCollection 2018. Dis Markers. 2018. PMID: 30245752 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical